do glp 1 cause muscle wasting Glucagon-like peptide-1 receptor agonists and mass effects GLP-1 & Muscle Loss: Evidence

Unlike many psoriatic arthritis treatments, GLP-1 receptor agonists do not suppress the immune system

When used with PET scans, this innovative technology gives physicians a clearer image of prostate cancer lesions and enables providers to determine the best course of treatment

Administered through weekly subcutaneous injections , Wegovy has demonstrated remarkable efficacy in clinical trials, helping patients achieve significant weight reduction while offering additional medical benefits

Phase 1/2 data on dosing and titration are expected by the first half of 2024, with more results anticipated in 2025

"This study highlights the use of genetics in understanding medication effects, especially when corresponding clinical experimental evidence is limited," said Professor Ryan Au Yeung Shiu-lun, Assistant Professor in the School of Public Health, HKUMed